晶苑(02232.HK)逆漲15%越50天線 為港府生產重用口罩
晶苑國際(02232.HK)為港府生產可重用 「銅芯抗疫口罩」,該股今早一舉升破10天、20天及50天線(2.2元),最高見2.32元,半日收2.3元,急漲15%,一向薄弱的成交半日急增至493萬股,涉資1,102萬元。
創新及科技局常任秘書長蔡淑嫻於電台證實,晶苑國際位於越南的生產線為港府生產可重用 「銅芯抗疫口罩」。蔡淑嫻解釋當初不公開生產商名稱,是不想麻煩對方,昨日徵求同意後決定公開生產商身份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.